Industry Leader’s Fireside Chat: Aligning the Future of In Vivo & Ex Vivo Cell Therapies for Greater Clinical & Commercial Impact
8:45 am - Tuesday 9th February 2027
- Reviewing how emerging clinical data is shaping market perspectives on in vivo cell therapies to guide smart pipeline decisions
- Examining the resurgence of next-generation in vivo CAR-Ts and ex vivo explorations for solid tumours and autoimmune disease to identify where each modality can unlock the greatest opportunity
- Aligning scientific, manufacturing, regulatory and commercial perspectives on the future direction of the field to accelerate clinical impact
